248 related articles for article (PubMed ID: 30122421)
1. Fingolimod modulates T cell phenotype and regulatory T cell plasticity in vivo.
Dominguez-Villar M; Raddassi K; Danielsen AC; Guarnaccia J; Hafler DA
J Autoimmun; 2019 Jan; 96():40-49. PubMed ID: 30122421
[TBL] [Abstract][Full Text] [Related]
2. Recognition of viral and self-antigens by T
Paroni M; Maltese V; De Simone M; Ranzani V; Larghi P; Fenoglio C; Pietroboni AM; De Riz MA; Crosti MC; Maglie S; Moro M; Caprioli F; Rossi R; Rossetti G; Galimberti D; Pagani M; Scarpini E; Abrignani S; Geginat J
J Allergy Clin Immunol; 2017 Sep; 140(3):797-808. PubMed ID: 28237728
[TBL] [Abstract][Full Text] [Related]
3. Treatment effects of fingolimod in multiple sclerosis: Selective changes in peripheral blood lymphocyte subsets.
Hjorth M; Dandu N; Mellergård J
PLoS One; 2020; 15(2):e0228380. PubMed ID: 32012202
[TBL] [Abstract][Full Text] [Related]
4. Clinical Remission of Sight-Threatening Non-Infectious Uveitis Is Characterized by an Upregulation of Peripheral T-Regulatory Cell Polarized Towards T-bet and TIGIT.
Gilbert RM; Zhang X; Sampson RD; Ehrenstein MR; Nguyen DX; Chaudhry M; Mein C; Mahmud N; Galatowicz G; Tomkins-Netzer O; Calder VL; Lightman S
Front Immunol; 2018; 9():907. PubMed ID: 29774027
[TBL] [Abstract][Full Text] [Related]
5. Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients.
Kürtüncü M; Yılmaz V; Akçay Hİ; Türkoğlu R; Altunrende B; Çınar SA; Ulusoy C; Gündüz T; İçöz S; Kasap M; Çalışkan Z; Ötünç G; Eraksoy M; Tüzün E
J Neuroimmunol; 2019 Dec; 337():577065. PubMed ID: 31526917
[TBL] [Abstract][Full Text] [Related]
6. Fingolimod modulates peripheral effector and regulatory T cells in MS patients.
Serpero LD; Filaci G; Parodi A; Battaglia F; Kalli F; Brogi D; Mancardi GL; Uccelli A; Fenoglio D
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1106-13. PubMed ID: 23649711
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CD4+ and CD8+ T Cell Subsets and Interferon Regulatory Factor 4 (IRF4) in MS Patients Treated with Fingolimod (FTY-720): A Follow-up Study.
Laribi B; Sahraian MA; Shekarabi M; Emamnejad R; Marzban M; Sadaghiani S; Izad M
Iran J Allergy Asthma Immunol; 2018 Aug; 17(4):346-360. PubMed ID: 30537798
[TBL] [Abstract][Full Text] [Related]
8. Fingolimod does not impair T-cell release from the thymus and beneficially affects Treg function in patients with multiple sclerosis.
Haas J; Schwarz A; Korporal-Kunke M; Jarius S; Wiendl H; Kieseier BC; Wildemann B
Mult Scler; 2015 Oct; 21(12):1521-32. PubMed ID: 25583847
[TBL] [Abstract][Full Text] [Related]
9. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
[TBL] [Abstract][Full Text] [Related]
10. Serotonin decreases the production of Th1/Th17 cytokines and elevates the frequency of regulatory CD4
Sacramento PM; Monteiro C; Dias ASO; Kasahara TM; Ferreira TB; Hygino J; Wing AC; Andrade RM; Rueda F; Sales MC; Vasconcelos CC; Bento CAM
Eur J Immunol; 2018 Aug; 48(8):1376-1388. PubMed ID: 29719048
[TBL] [Abstract][Full Text] [Related]
11. Baseline Differences in Minor Lymphocyte Subpopulations may Predict Response to Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients.
Teniente-Serra A; Hervás JV; Quirant-Sánchez B; Mansilla MJ; Grau-López L; Ramo-Tello C; Martínez-Cáceres EM
CNS Neurosci Ther; 2016 Jul; 22(7):584-92. PubMed ID: 27080413
[TBL] [Abstract][Full Text] [Related]
12. Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis.
Sato DK; Nakashima I; Bar-Or A; Misu T; Suzuki C; Nishiyama S; Kuroda H; Fujihara K; Aoki M
J Neuroimmunol; 2014 Mar; 268(1-2):95-8. PubMed ID: 24507619
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.
Wu Q; Wang Q; Mao G; Dowling CA; Lundy SK; Mao-Draayer Y
J Immunol; 2017 Apr; 198(8):3069-3080. PubMed ID: 28258191
[TBL] [Abstract][Full Text] [Related]
14. The effect of fingolimod on regulatory T cells in a mouse model of brain ischaemia.
Malone K; Diaz Diaz AC; Shearer JA; Moore AC; Waeber C
J Neuroinflammation; 2021 Jan; 18(1):37. PubMed ID: 33516262
[TBL] [Abstract][Full Text] [Related]
15. Depletion of FoxP3
Wang J; Müller S; Lin R; Siffert M; Vuitton DA; Wen H; Gottstein B
Immun Inflamm Dis; 2017 Dec; 5(4):435-447. PubMed ID: 28621034
[TBL] [Abstract][Full Text] [Related]
16. Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis.
Blumenfeld S; Staun-Ram E; Miller A
J Autoimmun; 2016 Jun; 70():40-51. PubMed ID: 27055778
[TBL] [Abstract][Full Text] [Related]
17. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
18. Ex-Th17 (Nonclassical Th1) Cells Are Functionally Distinct from Classical Th1 and Th17 Cells and Are Not Constrained by Regulatory T Cells.
Basdeo SA; Cluxton D; Sulaimani J; Moran B; Canavan M; Orr C; Veale DJ; Fearon U; Fletcher JM
J Immunol; 2017 Mar; 198(6):2249-2259. PubMed ID: 28167631
[TBL] [Abstract][Full Text] [Related]
19. S1P
Eken A; Duhen R; Singh AK; Fry M; Buckner JH; Kita M; Bettelli E; Oukka M
Sci Rep; 2017 Oct; 7(1):12905. PubMed ID: 29018225
[TBL] [Abstract][Full Text] [Related]
20. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
